Scientists re-engineer Patient's own cells to hunt lymphoma
NCT ID NCT01192464
Summary
This early-phase study is testing the safety of a new cell therapy for patients with Hodgkin's or Non-Hodgkin's lymphoma that has come back after standard treatment. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack lymphoma cells, and then infuse them back into the patient. The main goal is to see if this approach is safe and to find the right dose, while also checking if the modified cells survive and have any effect on the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN'S LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.